Elevated 5-LO and leukotriene signaling is reported in various forms of cancers, including cancer of the pancreas, colon, stomach, prostate, ovaries, and lungs (Wang and Dubois, 2010; Jala et al., 2017). Here, ALOX5 is linked to pancreatic neoplasm.